|
Stanford University |
Kenneth Weinberg |
Transplantation Immunology |
“Engineered immune tolerance by Stem Cell-derived thymic regeneration” |
$1,415,836 |
|
Beckman Research Institute of City of Hope |
David DiGiusto |
Early Translational II |
Development of RNA-based approaches to stem cell gene therapy for HIV |
$3,124,130 |
|
University of California, San Diego |
Lawrence Goldstein |
Tools and Technologies II |
Developing a method for rapid identification of high-quality disease specific hIPSC lines |
$1,816,157 |
|
Stanford University |
Christopher Zarins |
Comprehensive Grant |
Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells |
$2,618,704 |
|
University of California, San Francisco |
Ophir Klein |
New Faculty II |
Laying the groundwork for building a tooth: analysis of dental epithelial stem cells |
$3,250,251 |
|
Palo Alto Institute for Research and Education, Inc. |
Tony Wyss-Coray |
Basic Biology II |
Systemic Protein Factors as Modulators of the Aging Neurogenic Niche |
$1,522,800 |
|
University of California, Irvine |
Hans Keirstead |
Comprehensive Grant |
hESC-Derived Motor Neurons For the Treatment of Cervical Spinal Cord Injury |
$2,396,932 |
|
University of California, San Francisco |
Emmanuelle Passegue |
New Faculty II |
Mechanisms Underlying the Responses of Normal and Cancer Stem Cells to Environmental and Therapeutic Insults |
$2,274,368 |
|
University of California, Los Angeles |
Douglas Black |
Basic Biology II |
Programs of alternative splicing regulation by polypyrimidine tract binding protein |
$1,350,994 |
|
University of California, San Francisco |
Arnold Kriegstein |
Comprehensive Grant |
Derivation of Inhibitory Nerve Cells from Human Embryonic Stem Cells |
$2,507,223 |
|
University of Southern California |
Qilong Ying |
New Faculty II |
Mechanisms Underlying the Diverse Functions of STAT3 in Embryonic Stem Cell Fate Regulation |
$2,413,650 |
|
University of California, Los Angeles |
Yong Kim |
Basic Biology II |
Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells |
$1,259,371 |
|
University of California, Los Angeles |
Antoni Ribas |
New Faculty II |
Stem Cells for Immune System Regeneration to Fight Cancer |
$3,247,000 |
|
Stanford University |
Renee Reijo Pera |
Comprehensive Grant |
Human oocyte development for genetic, pharmacological and reprogramming applications |
$2,469,104 |
|
San Diego State University |
Ricardo Zayas |
New Faculty II |
The molecular basis underlying adult neurogenesis during regeneration and tissue renewal |
$1,725,830 |
|
Stanford University |
Steven Artandi |
Basic Biology II |
Self-renewal and senescence in iPS cells derived from patients with a stem cell disease |
$1,430,908 |
|
The J. David Gladstone Institutes |
Benoit Bruneau |
New Faculty II |
Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors |
$2,847,600 |
|
Escape Therapeutics, Inc |
Basil Hantash |
Transplantation Immunology |
Development of an immune tolerant hESC source for allogeneic cell therapy applications |
$1,453,040 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Comprehensive Grant |
microRNA Regulation of Cardiomyocyte Differentiation from Human Embryonic Stem Cells |
$3,164,000 |
|
Sanford-Burnham Medical Research Institute |
Stuart Lipton |
Comprehensive Grant |
MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells |
$3,035,996 |
|
Sanford-Burnham Medical Research Institute |
Huei-sheng Chen |
Basic Biology II |
Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes |
$1,823,362 |
|
University of California, Los Angeles |
Brigitte Gomperts |
New Faculty II |
Stem Cells in Lung Cancer |
$2,556,572 |
|
Palo Alto Institute for Research and Education, Inc. |
Husein Hadeiba |
Transplantation Immunology |
Application of Tolerogenic Dendritic Cells for Hematopoietic Stem Cell Transplantation |
$885,475 |
|
University of California, Los Angeles |
Guoping Fan |
Comprehensive Grant |
Epigenetic gene regulation during the differentiation of human embryonic stem cells: Impact on neural repair |
$2,516,613 |
|
Stanford University |
Irving Weissman |
Comprehensive Grant |
Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells |
$2,636,900 |
|
University of California, San Francisco |
John Rubenstein |
Basic Biology II |
MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells |
$1,387,800 |
|
Ludwig Institute for Cancer Research |
Bing Ren |
New Faculty II |
Mechanisms of chromatin dynamics at enhancers during ES cell differentiation |
$1,726,564 |
|
University of California, Los Angeles |
Gay Crooks |
Transplantation Immunology |
Engineering Thymic Regeneration to Induce Tolerance |
$1,357,398 |
|
University of California, San Francisco |
Susan Fisher |
Comprehensive Grant |
Constructing a fate map of the human embryo |
$2,532,388 |
|
University of California, Irvine |
Peter Donovan |
Comprehensive Grant |
Improved hES Cell Growth and Differentiation |
$2,509,438 |
|
Stanford University |
Garry Nolan |
Basic Biology II |
Kinase signaling analysis of iPS cell reprogramming and differentiation |
$1,447,956 |
|
University of California, San Diego |
Shyni Varghese |
New Faculty II |
A Novel Microenvironment-Mediated Functional Skeletal Muscle from Human Embryonic Stem Cells and their In Vivo Engraftment |
$2,300,569 |
|
The Salk Institute for Biological Studies |
Fred Gage |
Comprehensive Grant |
Molecular and Cellular Transitions from ES Cells to Mature Functioning Human Neurons |
$2,879,210 |
|
University of California, San Francisco |
Andrew Leavitt |
Comprehensive Grant |
Understanding hESC-based Hematopoiesis for Therapeutic Benefit |
$2,566,702 |
|
University of California, Irvine |
Aileen Anderson |
Basic Biology II |
Role of the microenvironment in human iPS and NSC fate and tumorigenesis |
$1,284,921 |
|
University of California, San Francisco |
Robert Blelloch |
New Faculty II |
Mechanisms of small RNA regulation in early embryonic development |
$3,204,897 |
|
University of California, San Francisco |
Mark Anderson |
Transplantation Immunology |
Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells
|
$1,314,090 |
|
University of California, San Diego |
Lawrence Goldstein |
Comprehensive Grant |
Using Human Embryonic Stem Cells to Understand and to Develop New Therapies for Alzheimer's Disease |
$2,512,664 |
|
University of California, Irvine |
Douglas Wallace |
Comprehensive Grant |
The Dangers of Mitochondrial DNA Heteroplasmy in Stem Cells Created by Therapeutic Cloning |
$2,530,000 |
|
University of California, Irvine |
Marian Waterman |
Basic Biology II |
TCF-3: A Wnt Pathway Effector and Nanog Regulator in Pluripotent Stem Cell Self-Renewal |
$1,277,101 |
|
Children's Hospital of Los Angeles |
Tracy Grikscheit |
New Faculty II |
Mechanism of Tissue Engineered Small Intestine Formation |
$3,415,000 |
|
University of California, San Diego |
Martin Marsala |
Comprehensive Grant |
Spinal ischemic paraplegia: modulation by human embryonic stem cell implant |
$2,445,716 |
|
University of California, Los Angeles |
Gay Crooks |
Comprehensive Grant |
Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC) |
$2,551,088 |
|
University of California, San Diego |
Dong-Er Zhang |
Basic Biology II |
RUNX1 in maintenance, expansion, and differentiation of therapeutic pluripotent stem cells |
$1,371,540 |
|
University of California, San Francisco |
Holger Willenbring |
New Faculty II |
Molecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells |
$3,207,510 |
|
Sanford-Burnham Medical Research Institute |
Mark Mercola |
Comprehensive Grant |
Chemical Genetic Approach to Production of hESC-derived Cardiomyocytes |
$3,036,002 |
|
University of California, Davis |
Mark Zern |
Comprehensive Grant |
An in vitro and in vivo comparison among three different human hepatic stem cell populations |
$2,504,614 |
|
University of California, San Diego |
Kun-Liang Guan |
Basic Biology II |
The function of YAP in human embryonic stem cells |
$1,340,565 |
|
The J. David Gladstone Institutes |
Yadong Huang |
New Faculty II |
Defining the Isoform-Specific Effects of Apolipoprotein E on the Development of iPS Cells into Functional Neurons in Vitro and in Vivo |
$2,847,600 |
|
Stanford University |
Christopher Contag |
Transplantation Immunology |
Engineering Embryonic Stem Cell Allografts for Operational Tolerance |
$1,447,956 |
|
Stanford University |
Stefan Heller |
Comprehensive Grant |
Generation of inner ear sensory cells from human ES cells toward a cure for deafness |
$2,469,373 |
|
University of California, Los Angeles |
Benhur Lee |
Basic Biology II |
The EphrinB2/EphB4 axis in regulating hESC pluripotency and differentiation |
$1,371,936 |
|
University of California, San Diego |
Benjamin Yu |
New Faculty II |
Regulation of Adult Stem Cell Proliferation by RAS and Cell-Permeable Proteins |
$3,231,649 |
|
University of California, San Francisco |
Randall Lee |
Comprehensive Grant |
Embryonic Stem Cell-Derived Therapies Targeting Cardiac Ischemic Disease |
$2,524,617 |
|
Stanford University |
Aaron Hsueh |
Basic Biology II |
Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation |
$1,432,197 |
|
Stanford University |
Ching-Pin Chang |
New Faculty II |
VEGF signaling in adventitial stem cells in vascular physiology and disease |
$3,330,931 |
|
Scripps Research Institute |
Jeanne Loring |
Transplantation Immunology |
Thymus based tolerance to stem cell therapies |
$1,269,844 |
|
Stanford University |
Roel Nusse |
Comprehensive Grant |
Guiding the developmental program of human embryonic stem cells by isolated Wnt factors |
$2,354,820 |
|
The Salk Institute for Biological Studies |
Ronald Evans |
Basic Biology II |
Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs |
$1,712,880 |
|
University of California, San Diego |
Catriona Jamieson |
New Faculty II |
Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells |
$3,065,572 |
|
University of California, Davis |
Alice Tarantal |
Comprehensive Grant |
Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells |
$2,257,040 |
|
iPierian, Inc. |
John Dimos |
Basic Biology II |
Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency |
$1,458,000 |
|
University of California, Irvine |
Edwin Monuki |
New Faculty II |
Mechanisms in Choroid Plexus Epithelial Development |
$3,169,328 |
|
University of California, San Francisco |
Jeffrey Bluestone |
Transplantation Immunology |
Stem cell tolerance through the use of engineered antigen-specific regulatory T cells |
$1,152,768 |
|
University of California, San Diego |
Yang Xu |
Comprehensive Grant |
Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells |
$2,570,000 |
|
University of California, Davis |
Eric Kurzrock |
Basic Biology II |
Differentiation of Human Embryonic Stem Cells into Urothelium |
$1,328,400 |
|
University of Southern California |
Gage DeKoeyer Crump |
New Faculty II |
Skeletogenic Neural Crest Cells in Embryonic Development and Adult Regeneration of the Jaw |
$2,396,871 |
|
University of California, San Francisco |
Tippi MacKenzie |
Transplantation Immunology |
Maternal and Fetal Immune Responses to In Utero Hematopoietic Stem Cell Transplantation |
$1,324,229 |
|
Stanford University |
Julie Baker |
Comprehensive Grant |
Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cell |
$2,628,635 |
|
University of California, San Francisco |
Jeremy Reiter |
New Faculty II |
High throughput modeling of human neurodegenerative diseases in embryonic stem cells |
$2,259,092 |
|
University of California, San Francisco |
Harold Bernstein |
Comprehensive Grant |
Modeling Myocardial Therapy with Human Embryonic Stem Cells |
$2,229,140 |
|
University of California, Merced |
Kara McCloskey |
New Faculty II |
Building Cardiac Tissue from Stem Cells and Natural Matrices |
$1,706,255 |
|
Stanford University |
Theo Palmer |
Comprehensive Grant |
Immunology of neural stem cell fate and function |
$2,501,125 |
|
University of California, Davis |
Paul Knoepfler |
New Faculty II |
Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency |
$2,158,161 |
|
University of California, San Francisco |
Samuel Pleasure |
Comprehensive Grant |
Human stem cell derived oligodendrocytes for treatment of stroke and MS |
$2,566,701 |
|
University of California, Berkeley |
Lin He |
New Faculty II |
The roles of non-coding RNAs in the self-renewal and differentiation of pluripotent stem cells |
$1,499,994 |
|
University of California, Los Angeles |
Zack Jerome |
Comprehensive Grant |
Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease |
$2,516,831 |
|
University of California, San Diego |
Mana Parast |
New Faculty II |
Molecular Mechanisms of Trophoblast Stem Cell Specification and Self-Renewal |
$3,253,580 |
|
Scripps Research Institute |
Nicholas Gascoigne |
Transplantation Immunology |
Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance |
$1,746,684 |
|
University of California, San Francisco |
Mitchel Berger |
Disease Team Research I |
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM) |
$19,162,435 |
|
University of Southern California |
Mark Humayun |
Disease Team Research I |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$18,904,916 |
|
University of California, San Diego |
Lawrence Goldstein |
Disease Team Research I |
Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis |
$10,857,762 |
|
Calimmune, Inc. |
Geoff Symonds |
Disease Team Research I |
GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE |
$8,278,722 |
|
University of California, Los Angeles |
Irvin Chen |
Early Translational from Disease Team Conversion |
HPSC based therapy for HIV disease using RNAi to CCR5. |
$1,505,000 |
|
University of California, San Diego |
Dennis Carson |
Disease Team Research I |
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) |
$19,999,826 |
|
Stanford University |
Alfred Lane |
Disease Team Research I |
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa |
$11,709,574 |
|
Beckman Research Institute of City of Hope |
Karen Aboody |
Disease Team Research I |
Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials |
$18,015,429 |
|
Stanford University |
Gary Steinberg |
Disease Team Research I |
Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke |
$20,000,000 |
|
University of California, Los Angeles |
Dennis Slamon |
Disease Team Research I |
THERAPEUTIC OPPORTUNITIES TO TARGET TUMOR INITIATING CELLS IN SOLID TUMORS |
$19,979,660 |
|
University of California, Los Angeles |
Donald Kohn |
Disease Team Research I |
Stem Cell Gene Therapy for Sickle Cell Disease |
$9,212,365 |
|
Stanford University |
Irving Weissman |
Disease Team Research I |
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$19,999,996 |
|
ViaCyte, Inc. |
Allan Robins |
Disease Team Research I |
Cell Therapy for Diabetes |
$22,999,937 |
|
Cedars-Sinai Medical Center |
Eduardo Marbán |
Disease Team Research I |
Autologous cardiac-derived cells for advanced ischemic cardiomyopathy |
$5,560,232 |
|
Beckman Research Institute of City of Hope |
John Zaia |
Disease Team Research I |
ZIinc Finger Nuclease-Based Stem Cell Therapy for AIDS |
$14,583,187 |
|
University of California, Los Angeles |
Irvin Chen |
Disease Team Research I |
HPSC based therapy for HIV disease using RNAi to CCR5. |
$9,905,604 |
|
Scripps Research Institute |
Jeanne Loring |
Shared Labs |
Center for hESC Research |
$3,828,751 |
|
Stanford University |
Renee Reijo Pera |
Shared Labs |
Center for Human Embryonic Stem Cell Research and Education |
$5,819,047 |
|
University of California, San Diego |
Karl Willert |
Shared Labs |
Enhancing Facilities for Genetic Manipulation and Engineering of Human Embryonic Stem Cells |
$3,711,102 |
|
Buck Institute for Age Research |
Xianmin Zeng |
Shared Labs |
CIRM Shared Research Laboratory for Stem Cells and Aging |
$5,883,026 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Shared Labs |
CIRM Shared Human Embryonic Stem Cell Core Laboratory |
$2,621,345 |